perindoprilat has been researched along with quinaprilat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jackson, B; Johnston, CI; Perich, RB | 1 |
| Hiromi, Y; Kato, K; Kawahara, H; Muraoka, I; Nabeshima, T; Seno, H; Takasu, R; Yamada, S | 1 |
1 trial(s) available for perindoprilat and quinaprilat
| Article | Year |
|---|---|
Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Chromatography, High Pressure Liquid; Half-Life; Humans; Hypertension; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Perindopril; Quinapril; Renal Dialysis; Renal Insufficiency; Tetrahydroisoquinolines | 2003 |
2 other study(ies) available for perindoprilat and quinaprilat
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Binding, Competitive; Bradykinin; Dipeptides; Indoles; Isoquinolines; Kidney; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Pyridazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Substrate Specificity; Testis; Tetrahydroisoquinolines | 1994 |